VANCOUVER, BRITISH COLUMBIA--(Marketwire - September 08, 2009) - Tekmira Pharmaceuticals Corporation (TSX: TKM) announced today that the Company’s President and Chief Executive Officer, Dr. Mark Murray, will present a corporate overview at the Rodman & Renshaw Annual Global Investment Conference on Thursday, September 10, 2009 at 4:05 pm ET at the New York Palace Hotel in New York City. A live webcast of the presentation will be available and can be accessed on the Company’s website, www.tekmirapharm.com.
Dr. Murray will also participate in a panel discussion on RNAi Therapeutics at the Rodman & Renshaw conference taking place Thursday, September 10, 2009 at 8:25 am ET.
About Tekmira
Tekmira Pharmaceuticals Corporation is a biopharmaceutical company focused on advancing novel RNAi therapeutics and providing its leading lipid nanoparticle delivery technology to pharmaceutical partners. Further information about Tekmira can be found at www.tekmirapharm.com. Tekmira is based in Vancouver, B.C.
Contacts:
The Equicom Group - Investors
Adam Peeler
416-815-0700 x 225
apeeler@equicomgroup.com
Tekmira Pharmaceuticals Corporation - Investors
Ian Mortimer
Executive Vice President and Chief Financial Officer
604-419-3200
www.tekmirapharm.com
Longview Communications Inc. - Media
David Ryan
604-694-6031
dryan@longviewcomms.ca
